Literature DB >> 27514572

Association of testosterone and BDNF serum levels with craving during alcohol withdrawal.

Annemarie Heberlein1, Bernd Lenz2, Birgitt Opfermann3, Michael Gröschl4, Eva Janke5, Katrin Stange5, Adrian Groh5, Johannes Kornhuber2, Helge Frieling5, Stefan Bleich5, Thomas Hillemacher5.   

Abstract

Preclinical and clinical studies show associations between testosterone and brain-derived neurotrophic growth factor (BDNF) serum levels. BDNF and testosterone have been independently reported to influence alcohol consumption. Therefore, we aimed to investigate a possible interplay of testosterone and BDNF contributing to alcohol dependence. Regarding possible interplay of testosterone and BDNF and the activity of the hypothalamic pituitary axis (HPA), we included cortisol serum levels in our research. We investigated testosterone and BDNF serum levels in a sample of 99 male alcohol-dependent patients during alcohol withdrawal (day 1, 7, and 14) and compared them to a healthy male control group (n = 17). The testosterone serum levels were significantly (p < 0.001) higher in the patients' group than in the control group and decreased significantly during alcohol withdrawal (p < 0.001). The decrease of testosterone serum levels during alcohol withdrawal (days 1-7) was significantly associated with the BDNF serum levels (day 1: p = 0.008). In a subgroup of patients showing high cortisol serum levels (putatively mirroring high HPA activity), we found a significant association of BDNF and testosterone as well as with alcohol craving measured by the Obsessive and Compulsive Drinking Scale (OCDS). Our data suggest a possible association of BDNF and testosterone serum levels, which may be relevant for the symptomatology of alcohol dependence. Further studies are needed to clarify our results.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abstinence; Alcohol dependence; Alcohol withdrawal; BDNF; Testosterone

Mesh:

Substances:

Year:  2016        PMID: 27514572     DOI: 10.1016/j.alcohol.2016.06.004

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  4 in total

1.  Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.

Authors:  Jana Ruda-Kucerova; Zuzana Babinska; Tibor Stark; Vincenzo Micale
Journal:  Neurotox Res       Date:  2017-04-18       Impact factor: 3.911

2.  Investigating the link between serum concentrations of brain-derived neurotrophic factor and behavioral measures in anxious alcohol-dependent individuals.

Authors:  Jeanelle Portelli; Mehdi Farokhnia; Sara L Deschaine; Jillian T Battista; Mary R Lee; Xiaobai Li; Dorit Ron; Lorenzo Leggio
Journal:  Alcohol       Date:  2020-08-13       Impact factor: 2.405

3.  Evidence of a Relationship Between Plasma Leptin, Not Nesfatin-1, and Craving in Male Alcohol-Dependent Patients After Abstinence.

Authors:  Ya-Yun Xu; Jin-Fang Ge; Jun Chen; Jun Liang; Liang-Jun Pang; Wen-Fan Gao; Yin Cao; Feng Shan; Yang Liu; Chun-Yu Yan; Qing-Rong Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-24       Impact factor: 5.555

4.  Brain-derived neurotrophic factor and glutathione peroxidase as state biomarkers in alcohol use disorder patients undergoing detoxification.

Authors:  Shu-Yu Wu; Chien-Yu Chen; Tiao-Lai Huang; Meng-Chang Tsai
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.